The Pacific Meso Center (PMC) is known internationally for its research and clinical guidelines promoting lung-sparing therapies for malignant pleural mesothelioma (MPM). The PMC Laboratory is staffed by dedicated professionals in both nonprofit medical research management and scientific research. In 2011, Clare Cameron was recruited to serve as Executive Director of The PMC. Ms. Cameron’s professional background in medical research advocacy, combined with her personal and family challenges with lung cancer, make her the consummate administrator for an innovative research organization dedicated to finding new treatments for asbestos-related lung cancer. Ms. Cameron coordinates operational, research, and inter-agency collaborative functions of the PMC while ensuring that it fulfils its mission to improve treatment of MPM.
The research staff of PMC is composed of three full time research scientists who have the proven expertise needed to deliver high quality research to the communities we serve. Dr. Raymond Wong, who holds a Ph.D. in Molecular Microbiology and Immunology from the University of Southern California, is an experienced researcher in therapeutic cancer vaccines as well as immunotherapy for multiple cancertypes. Dr. Irina Ianculescu, also a graduate of the University of Southern California, received her doctorate in Genetics, Molecular and Cellular Biology. Dr. Ianculescu has worked extensively on the molecular biology of different types of cancers, including prostate cancer and MPM. Dr. Dongmei Hou, who holds a Ph.D. and M.D. from universities in China and Japan, received postdoctoral training at the University of California at Los Angeles. Dr. Hou’s research specializations include hyperthermia therapy, chemotherapy, and immunotherapy for the treatment of MPM.
The PMC research team is a “mini bench think tank” of highly skilled scientists working together toward a common goal of alleviating the suffering of patients diagnosed with MPM. The team’s combined expertise in immunotherapy, one of the most promising areas of cancer research today, eventually may help to enhance the survival rates and improve the quality of life in patients with MPM. The PMC research staff currently focuses on early stage exploratory studies, and their cutting-edge investigations may help other scientists discover effective interventions to treat solid cancers and blood cancers as well as MPM.
The PMC staff also collaborates with world-renowned scientists focused on eradicating MPM. Our onsite researchers’ commitment to fulfill the mission and goals of PMC reflects an unrelenting drive toward scientific excellence and a deep empathy for the tens of thousands of patients living with MPM.